There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Rocket Pharmaceuticals Inc (NASDAQ:RCKT) and Strongbridge Biopharma Plc (NASDAQ:SBBP) with bullish sentiments.
Rocket Pharmaceuticals Inc (RCKT)
In a report released today, Raju Prasad from William Blair initiated coverage with a Buy rating on Rocket Pharmaceuticals Inc. The company’s shares opened today at $21.24, close to its 52-week high of $24.28.
According to TipRanks.com, Prasad is a 4-star analyst with an average return of 13.8% and a 52.9% success rate. Prasad covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Audentes Therapeutics, and Krystal Biotech Inc.
Rocket Pharmaceuticals Inc has an analyst consensus of Moderate Buy.
See today’s analyst top recommended stocks >>
Strongbridge Biopharma Plc (SBBP)
In a report released today, Hartaj Singh from Oppenheimer maintained a Buy rating on Strongbridge Biopharma Plc. The company’s shares opened today at $5.35.
According to TipRanks.com, Singh is a 4-star analyst with an average return of 9.9% and a 49.7% success rate. Singh covers the Healthcare sector, focusing on stocks such as Syndax Pharmaceuticals Inc, Catabasis Pharmaceuticals, and Actinium Pharmaceuticals.
Strongbridge Biopharma Plc has an analyst consensus of Strong Buy, with a price target consensus of $17.50, a 227.1% upside from current levels. In a report released today, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $17 price target.
.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
